Credit: Celltrion Edenzelt is a vascular endothelial growth factor inhibitor. Findings from the phase 3 study showed therapeutic equivalence between the biosimilar and reference product. The Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results